Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. Focusing on adherence to these 3 simple interventions (by ...
Randomized Prospective Trial Exploring the Impact of Structured Journaling in Patients With Sarcoma on the Management of Treatment-Related Adverse Events Many patient population groups are not ...
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer (BLOSSOM) ...
In a previous analysis of this phase 3 trial, first-line ribociclib plus letrozole resulted in significantly longer progression-free survival than letrozole alone among postmenopausal patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback